
Tenvir-em
Tenofovir Disoproxil, Emtricitabine
300mg + 200mg
Tenofovir and emtricitabine tablets for HIV and pre-exposure prophylaxis. Combining two antivirals lowers the risk of resistance.
Antiretroviral tablets for HIV-1 treatment fill this range, from single-ingredient options such as Tivicay and Sustiva to combination tablets such as Biktarvy, Viropil and Tenvir-em, which also covers pre-exposure prophylaxis.

Tenofovir Disoproxil, Emtricitabine
300mg + 200mg
Tenofovir and emtricitabine tablets for HIV and pre-exposure prophylaxis. Combining two antivirals lowers the risk of resistance.

Bictegravir, Emtricitabine, Tenofovir Alafenamide
50mg + 200mg + 25mg
Bictegravir and emtricitabine tablets for HIV-1 infection. Two antiretrovirals work together to stop the virus from copying itself and spreading.

Dolutegravir, Lamivudine, Tenofovir Disoproxil
50mg + 300mg + 300mg
Dolutegravir and lamivudine tablets for HIV-1 infection. It blocks two different steps in the HIV lifecycle.

Tenofovir Disoproxil, Efavirenz, Emtricitabine
300mg + 600mg + 200mg
Tenofovir disoproxil and efavirenz tablets for HIV-1. They combine two antiretrovirals to keep the virus in check.
Tivicay contains dolutegravir, and Sustiva contains efavirenz, two antiretroviral ingredients that block different stages of HIV’s life cycle. Lamivudine is the single ingredient in Epivir, and it also appears in two of the combination tablets below.
Tenofovir disoproxil and emtricitabine are paired in Tenvir-em, which is also listed for pre-exposure prophylaxis alongside HIV-1 treatment. The same two ingredients appear again in Trustiva, alongside efavirenz, and tenofovir disoproxil also appears in Viropil, alongside dolutegravir and lamivudine. Biktarvy combines bictegravir, emtricitabine and tenofovir alafenamide, a related but distinct tenofovir form, into a single combination regimen. Combivir pairs lamivudine with zidovudine.